OptimizeRx Establishes Direct Partnership and Integration with NextGen Healthcare
July 23 2019 - 8:31AM
OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital
health messaging in the pharmaceutical industry, announced a new
partnership and integration with NextGen Healthcare, Inc. (Nasdaq:
NXGN). Providers using NextGen® Enterprise—a full suite of
comprehensive technology solutions including electronic health
record (EHR), practice management (PM) and revenue cycle management
(RCM) solutions—will have immediate access to OptimizeRx’s
real-time cloud-based platform.
“Teaming up with OptimizeRx allows us to provide our clinicians
real-time access to valuable pharmaceutical data and insights that
promote affordability and enhance quality care. As a result,
patients can better access and afford medications vital to their
overall well-being,” said John S. Beck, Chief Solutions Officer and
Executive Vice President, NextGen Healthcare.
The OptimizeRx platform will integrate directly into NextGen
Enterprise’s EHR workflow, enabling the extensive 55,000+
prescriber network real-time access to critical information from
key pharma manufacturers. Providers have access to patient
savings opportunities for many prescribed medications—a
particularly pertinent need of patients as a recent report by
TransUnion Healthcare indicated a 12 percent increase in
out-of-pocket healthcare costs in 2018. Additionally, direct EHR
integration means providers can, at the point of care, deliver
patient support and brand enrollment beyond the e-coupon to support
adherence and care.
“Given the financial landscape in today’s healthcare
environment, it’s more critical than ever that we work together to
bridge the communications gap between key stakeholders in the care
journey: providers, patients and the pharma industry,” said Will
Febbo, CEO at OptimizeRx. “Our partnership with NextGen Healthcare,
the leading provider of ambulatory-focused technology solutions,
will allow us to empower providers with critical patient savings
opportunities from the pharma industry—thus empowering the patient
with lowered costs and improved adherence rates. This marks a
significant step in the direction towards improving quality
care.”
For more information on OptimizeRx, its platform or its
partners, visit www.optimizerx.com.
About OptimizeRxOptimizeRx® (Nasdaq: OPRX), a
digital health company, connects pharmaceutical companies to
patients and providers, offering greater affordability, adherence
and brand awareness at the point-of-care. As the nation’s largest
point-of-prescribe promotional platform for the pharmaceutical
industry, OptimizeRx provides a direct channel
for pharma companies to communicate with healthcare
providers right within their workflow.
The cloud-based solution supports patient adherence to
medications with real-time access to financial assistance, prior
authorization, education and critical clinical
information. OptimizeRx provides more than half of the
ambulatory patient market with access to these benefits through
leading EHR platforms like Allscripts, Amazing Charts and
Quest, and directly via its mobile communications
platform.
For more information, follow the company on Twitter, LinkedIn or
visit www.optimizerx.com.
About NextGen Healthcare, Inc. NextGen
Healthcare provides a range of software, services, and analytics
solutions to medical and dental group practices. The company's
portfolio delivers foundational capabilities to empower physician
success, enrich the patient care experience, and enable the
transition to value-based healthcare.
Visit www.nextgen.com for additional information. Follow NextGen
Healthcare on Facebook, Twitter, LinkedIn and Instagram.
Important Cautions Regarding Forward Looking
Statements
This press release contains forward-looking statements within
the definition of Section 27A of the Securities Act of 1933, as
amended, and such as in section 21E of the Securities Act of 1934,
as amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
OptimizeRx Contact Doug
Baker, CFO Tel (248) 651-6568
x807 dbaker@optimizerx.com
Media Relations Contact Nicole
Brooks, Innsena Communications Tel (860) 800-2344 nicolebrooks@innsena.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
NextGen Healthcare Media Relations
ContactPriya DuaTel (949)
237-5254pdua@nextgen.com
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Apr 2023 to Apr 2024